FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.3157.1004.13

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113883.3.3157.1004.13
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.3157.1004.13/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.13
Version20240217
Statusactive
Date2024-02-17T01:10:27-05:00
NameDihydrocodeine
TitleDihydrocodeine
Realmus
Authorityhl7
Purpose(Clinical Focus: This set of semantic clinical drugs (SCD) and generic pack (GPCK) RxNorm codes aims to capture orders of the opioid medication dihydrocodeine.),(Data Element Scope: The intent of this data element is to identify patients who are prescribed dihydrocodeine.),(Inclusion Criteria: Include RxNorm SCD and GPCK type codes that identify dihydrocodeine medications.),(Exclusion Criteria: None.)

Resources that use this resource

ValueSet
2.16.840.1.113762.1.4.1046.241Schedule II, III and IV Opioid Medications

Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.3157.1004.13",
  "meta": {
    "versionId": "39",
    "lastUpdated": "2024-02-17T01:10:27.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Mathematica EP"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-04-03"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-02-17"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.13",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.3157.1004.13"
    }
  ],
  "version": "20240217",
  "name": "Dihydrocodeine",
  "title": "Dihydrocodeine",
  "status": "active",
  "date": "2024-02-17T01:10:27-05:00",
  "publisher": "Mathematica",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: This set of semantic clinical drugs (SCD) and generic pack (GPCK) RxNorm codes aims to capture orders of the opioid medication dihydrocodeine.),(Data Element Scope: The intent of this data element is to identify patients who are prescribed dihydrocodeine.),(Inclusion Criteria: Include RxNorm SCD and GPCK type codes that identify dihydrocodeine medications.),(Exclusion Criteria: None.)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "1596108",
            "display": "acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule"
          },
          {
            "code": "1812164",
            "display": "acetaminophen 325 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Tablet"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:faabcef8-99eb-4d0e-bd27-9f7db283a345",
    "timestamp": "2025-05-23T21:58:12-04:00",
    "total": 2,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1596108",
        "display": "acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1812164",
        "display": "acetaminophen 325 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Tablet"
      }
    ]
  }
}